22 Pesticides Linked to Prostate Cancer Risk
By Ernie Mundell HealthDay Reporter
TUESDAY, Nov. 5, 2024 -- Exposure to any one of 22 pesticides may bring heightened odds of developing prostate cancer, a new analysis suggests.
The study was conducted over decades because prostate cancer is known to grow very slowly, noted a team led by Dr. Simon John Christoph Soerensen, of Stanford University in California.
The researchers looked at U.S. data on county-level usage of 295 pesticides. They then compared those results to rates of prostate cancer in counties across the United States.
To account for the 10- to 18-year lag time between carcinogen exposure and the time it takes prostate cancers to grow, Soerensen's group looked at pesticide-use data from 1997 through 2001.
They then compared that data to rates of prostate cancer for the years 2016 through 2020.
Altogether, 22 pesticides had associations with upped prostate cancer risk, although the study could not prove cause-and-effect.
Three of the pesticides had already been linked previously to the cancer, including 2-4-D, a commonly used pesticide in the United States.
The findings were published Nov. 4 in the journal Cancer.
Of the other 19 pesticides, 10 were herbicides, while the others included fungicides and insecticides, plus a soil fumigant, the researchers reported.
High exposures to four of the pesticides were linked to the development of prostate cancer plus death from the disease.
Those chemicals included trifluralin, cloransulam-methyl and diflufenzopyr, plus one insecticide, thiamethoxam, the Stanford team said.
Of those four, only trifluralin is currently classed by the Environmental Protection Agency as a "possible human carcinogen," the team pointed out. The other three have been designated by the EPA as either “not likely to be carcinogenic” or having evidence of “non-carcinogenicity.”
“This research demonstrates the importance of studying environmental exposures, such as pesticide use, to potentially explain some of the geographic variation we observe in prostate cancer incidence and deaths across the United States,” Soerensen, a graduate student in epidemiology at Stanford, said in a journal news release. “By building on these findings, we can advance our efforts to pinpoint risk factors for prostate cancer and work towards reducing the number of men affected by this disease.”
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-06 00:00
Read more
- Ozempic Curbs Kidney Disease in Obese People Without Diabetes
- 3 Years of Med School Might Be Enough to Produce Quality Doctors
- Different Forms of Childhood Adversity Tied to Different Psychiatric Problems
- Clinical Practice Guidelines Updated for Primary Prevention of Stroke
- FDA Appoints New Head of Medical Devices
- Frequent Social Media Use Harmful for High School Students
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions